MedTrace Logo

ACCESS A Master Digital Surveillance Protocol for COVID-19

NCT04363268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2023-05-25

No results posted yet for this study

Summary

ACCESS enables individuals to contribute to critical research, via an iOS and Android smartphone mobile application. ACCESS combines patient reported outcomes, data from wearable devices and real-world data (such as claims, EHRs, etc), with an opt-in to participate in current and future studies for diagnostics, treatments and vaccines. The data that people share can be quickly and anonymously matched to research studies, providing researchers with a foundational framework for dynamic research at scale and participants a way to be personally matched and prescreened for future research.

Conditions

Sponsors & Collaborators

  • Datavant

    collaborator INDUSTRY

  • American Heart Association

    collaborator OTHER

  • BioIntelliSense

    collaborator UNKNOWN

  • PWNHealth

    collaborator UNKNOWN

  • Medable Inc.

    lead OTHER

Principal Investigators

  • Ingrid Oakley-Girvan, PhD · Medable Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04363268 on ClinicalTrials.gov